Visken

Active Ingredient(s): Pindolol
FDA Approved: * September 3, 1982
Pharm Company: * NOVARTIS
Category: Blood Pressure

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Visken Overview

Pindolol, sold under the brand name Visken among others, is a beta blocker which is used in the treatment of hypertension and angina pectoris.[1][2] It is also an antagonist of the serotonin 5-HT1A receptor, preferentially blocking inhibitory 5-HT1A autoreceptors, and has been researched as an add-on therapy to selective serotonin reuptake inhibitors (SSRIs) in the treatment of depression,[3][4] though with little or no effective...

Read more Visken Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Pindolol

Recent Visken Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Pindolol
  • Tablet: 10mg, 5mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Visken: (2 results)

Sorted by National Drug Code
  • 0078-0073 Visken 10 mg Oral Tablet by Novartis Pharmaceuticals Corporation
  • 0078-0111 Visken 5 mg Oral Tablet by Novartis Pharmaceuticals Corporation

Other drugs which contain Pindolol or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 18 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA